A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|1 May 2017||Submitted||Original manuscript|
|29 May 2017||Reviewed||Reviewer Report - Kasia Stepniewska|
|6 Jun 2017||Reviewed||Reviewer Report - Sam Salman|
|9 Jun 2017||Reviewed||Reviewer Report - Cor Jesus Fontes|
|2 Aug 2017||Author responded||Author comments - Fiona Macintyre|
|Resubmission - Version 2|
|2 Aug 2017||Submitted||Manuscript version 2|
|6 Aug 2017||Reviewed||Reviewer Report - Cor Jesus Fontes|
|22 Aug 2017||Reviewed||Reviewer Report - Kasia Stepniewska|
|4 Sep 2017||Author responded||Author comments - Fiona Macintyre|
|Resubmission - Version 3|
|4 Sep 2017||Submitted||Manuscript version 3|
|5 Sep 2017||Editorially accepted|
|9 Oct 2017||Article published||10.1186/s12916-017-0940-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.